
|Articles|August 7, 2008
Now there's an echinocandin antifungal to treat kids
Cancidas, previously approved for use in adults, can now be applied also to pediatric patients aged three months to 17 years.
Advertisement
Merck's Cancidas (caspofungin acetate), previously approved for use in adults, can now be applied also to pediatric patients aged three months to 17 years. The Whitehouse Station, N.J., firm claims that the approval makes
To see more Daily News articles,
To go to the Drug Topics homepage,
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
How Pharmacists Take Control of Medical Billing
2
Pharmacists Essential for Managing Patient Safety in Self-Medication
3
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
4
COVID-19 Booster Comparison Shows Higher Antibody Levels With mRNA Vaccine
5






























